AOD 9604
Overview:
AOD 9604 (Advanced Obesity Drug 9604) is a synthetic peptide fragment of human growth hormone (hGH), consisting of 16 amino acids derived from the C terminal region of the hormone. It was developed to study lipid metabolism and fat reduction mechanisms without activating the growth related effects typically associated with full length hGH. AOD 9604 is researched for its selective action on fat metabolism pathways while minimizing systemic hormonal activity.
Key Benefits
• Supports lipid metabolism and fat oxidation in experimental models
• Influences adipose tissue regulation without stimulating growth pathways
• Studied for its role in lipolysis and reduced fat accumulation
• Does not significantly activate IGF 1–mediated growth effects
• Researched for potential applications in weight management and metabolic studies
Specification
• Strength: 10 mg per vial
• Form: Lyophilized powder
• Purity: ≥ 98% (HPLC)
Usage
Typically reconstituted with bacteriostatic water and administered via subcutaneous injection under professional guidance. Dosage varies based on individual goals and medical supervision.